This document presents an overview of transporters as targets for drugs. Transporters are membrane proteins that control the movement of drugs across biological barriers through various transport mechanisms. There are two main types of transporters - ATP-binding cassette (ABC) transporters and solute carrier (SLC) transporters. ABC transporters use ATP hydrolysis to actively transport substrates while SLC transporters use ion gradients to facilitate transport. Transporters play important roles in pharmacokinetic and pharmacodynamic pathways but can also contribute to drug resistance. Targeting transporters offers opportunities to modulate drug absorption, distribution, and resistance.
Review on various families of drug transporters in our body, their functions & drugs acting through them & drug interactions involving these transporters
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with pharmacokinetics : concept of linear and non-linear compartment models.
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
Review on various families of drug transporters in our body, their functions & drugs acting through them & drug interactions involving these transporters
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with pharmacokinetics : concept of linear and non-linear compartment models.
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
Non adrenergic non cholinergic transmission(nanc)Merlin Binu
Neurotransmitters other than Acetyl choline and NorAdrenaline of parasympathetic and sympathetic nervous system play important role in synaptic junction transmission. That neurotransmitters are called NANC.
General description about various types of receptor, their classification, mechanism of action and its clinical significance, along with recent advances.
Non adrenergic non cholinergic transmission(nanc)Merlin Binu
Neurotransmitters other than Acetyl choline and NorAdrenaline of parasympathetic and sympathetic nervous system play important role in synaptic junction transmission. That neurotransmitters are called NANC.
General description about various types of receptor, their classification, mechanism of action and its clinical significance, along with recent advances.
Drug delivery systems has undergone major modification in the recent past . With the advent of nanomedicines and liposomes , drug delivery systems has taken a huge leap towards targeted, carrier mediated and sustained release drug delivery.
The presentation captures the IP activity along with the key players in the smart drug delivery system industry. The presentation also captures the distribution of patents across the world. The IP information, competitor activity and the technology classification are also included. Prior art problems and their respective solutions given in different patents are captured in addition to the taxonomy nodes (technology breakdown classification). Product analysis is done for seven products.
As the global biosimilars market opens up, what do physicians faced with choosing between prescribing a brand-name biologic or biosimilar think – and know?
Fixed dose combination products – rationality, status in india, development i...Dr Sukanta sen
The development of FDCs is becoming increasingly
important from a public health perspective.
•They are being used in the treatment of a wide range of
conditions and are particularly useful in the management of
human immunodeficiency virus/acquired immunodeficiency
syndrome (HIV/AIDS), malaria and tuberculosis, which are
considered to be the foremost infectious disease threats in the world today.
primary and secondary active transport difference,Computer aided drug design P glycoprotein transport,bcrp,nt,Abst,oATP,oct,BBB choline transporter,hpepti
Myself Omkar Tipugade , M- Pharm ,Sem - II, Department of pharmaceutics , from Shree Santkrupa College Of Pharmacy , ghogaon . Today I upload presentation on Active Transport like P-gp , BCPR, Nucleoside transporters etc .
Transporter superfamilies in the human genomeAkash Agnihotri
Transporter superfamilies in the human genome.
This includes 2 main families of transporters- SCL and ABC superfamily and their functions, locations, and sub-classification with their related disorders and drug interactions.
Also,
Transporters in pharmacokinetics
Movement of drug across cellular membrane
SLC Gene Nomenclature System
Solute Carrier Proteins (SLCs)
SLC transporters and diseases
SLC types of transporters- OAT Family, OAT Family (with example)
ABC Transporter Nomenclature System
Human ABC Superfamily
Tissue Distribution of Drug-Related ABC Transporters
ABC transporters form barriers
ABC Transporters in Drug Absorption and Elimination
This PowerPoint Presentation is fully academic. Pictures and Photos added here are randomly selected from the net so as to understand the subject in a better way. This will be helpful for the learner and learned learners and teachers
A brief presentation about the transport of drugs across the cell membrane including the many mechanisms and various transporters and a brief overview of the ABC and SLC superfamily of transporters.
The need for continual training program as a part of cGMP in pharmaceutical i...shikha singh
Continual training program carried out in pharmaceutical industries through out the year for the attainment and betterment of the employees and for the growth of the company
This ppt is quite helpful for students/ researchers to understand the mechanism behind ethosomes penetration in the skin barrier when applied topically as well as it helps you to brief on drug detailing while formulating the ethosomes formulation.
for any more question you want to ask, feel free to contact: shikhasingh_ss@yahoo.com
thank you!
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
1. TRANSPORTERS AS TARGETS
FOR DRUGS
P R E S E N T E D B Y : S H I K H A Y . S I N G H
U N D E R T H E G U I D A N C E O F : D R . K B K O T E S H W A R A
D E P A R T M E N T O F P H A R M A C E U T I C S
R E G I S T R A T I O N N O . 1 6 0 6 1 7 0 0 9
ManipalCollegeofPharmaceuticalSciences(MCOPS)
2. TRANSPORTERS AS TARGETS FOR DRUGS
• INTRODUCTION
• TRANSPORTERS
• TYPES OF TRANSPORTERS
• MEMBRANE TRANSPORT & DRUG RESISTANCE
• PHARMACOKINECTIC PATHWAYS
• CONCLUSION
• REFERENCES
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
2
ManipalCollegeofPharmaceuticalSciences(MCOPS)
CONTENTS
3. TRANSPORTERS AS TARGETS FOR DRUGS
• WHAT IS BIO-TRANSPORT?
• The movement of drug from one side of the biological barrier to other is called Bio-transport
• The mechanisms involved in transfer of drugs across the biological barrier called Transport
mechanisms
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
3
INTRODUCTION
ManipalCollegeofPharmaceuticalSciences(MCOPS)
4. 4
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
MECHANISM OF MEMBRANE PERMEATION
TRANSPORTERS AS TARGETS FOR DRUGSManipalCollegeofPharmaceuticalSciences(MCOPS)
6. • Transporters are membrane proteins that are present in all organisms
• These proteins controls
• Drug-transporting proteins operate in
pharmacokinetic pathways
pharmacodynamic pathways
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
6
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS
TRANSPORTERS AS TARGETS FOR DRUGS
Efflux of cellular waste, environmental
toxins, & other xenobiotics
Influx of essential nutrients & ions
7. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
7
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TYPES OF TRANSPORTERS
• 2000 genes in the human genome (7% of the total number of genes) code for
transporters or transporter-related proteins
• Transporters are of two major superfamilies
TRANSPORTERS AS TARGETS FOR DRUGS
TRANSPORTERS
1.ABC
TRANSPORTERS
1.SLC
TRANSPORTERS
8. 8
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
1. ATP BINDING CASSETTE TRANSPORTERS
• Most ABC proteins are primary active transporters
• 49 known genes for ABC proteins that can be grouped into 7 subclasses from
ABCA to ABCG
• The best recognized in the ABC superfamily are
I. P-glycoprotein (P-gp encoded by ABCB1, also termed MDR1)
II. Cystic fibrosis transmembrane regulator (CFTR)
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
ManipalCollegeofPharmaceuticalSciences(MCOPS)
9. TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF ABC TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
ManipalCollegeofPharmaceuticalSciences(MCOPS)
10. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
10
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF ABC TRANSPORTERS...
• ABC transporter consist of two distinct domains
Transmembrane domain (TMD)
• Membrane-spanning domain (MSD) or Integral membrane
(IM) domain
• Consists of alpha helices, embedded in the membrane bilayer
Nucleotide-binding domain (NBD)
• Site for ATP binding
• Located in the cytoplasm
11. EXPORTERS-
N-terminal & C-terminal that are fused as a single polypeptide chain,
Arranged as TMD-NBD-TMD-NBD
IMPORTERS-
Have an inverted organization i.e NBD-TMD-NBD-TMD
NBD domain is N-terminal whereas TMD is C-terminal
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
11
ManipalCollegeofPharmaceuticalSciences(MCOPS) TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF ABC TRANSPORTERS...
12. 12
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
MECHANISM BEHIND ABC TRANSPORTER
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
• As they are Active transporters they require energy in the form of ATP
• Conformational changes in the Transmembrane domain (TMD)
13. 13
GENE NAME FAMILY NAME NO. OF
FAMILIES
DISEASE ASSOCIATED
ABCA ABC A 12 Tangiers dis
Stargadts dis
ABCB ABC B 11 PFIHC
ABCC ABC C 13 Cystic fibrosis
Dubin Johnson syndrome
ABCD ABC D 4 Adreno-leukodystrophy
ABCE ABC E 1
ABCF ABC F 3
ABCG ABC G 5 Sitosterolemia
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
TYPE OF ABC TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
ManipalCollegeofPharmaceuticalSciences(MCOPS)
16. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
16
ManipalCollegeofPharmaceuticalSciences(MCOPS)
ANTICANCER DRUG:
•P-glycoprotein is overexpressed in tumor cells after exposure to cytotoxic
anticancer agents
•P-glycoprotein pumps out the anticancer drugs
•Competitive & allosteric agents are used to inhibit p-gp
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
ABC TRANSPORTER EXAMPLE
17. 17
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
2. SOLUTE CARRIER TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
• 48 SLC families with 315 transporters have been identified in the human genome
• SLC subfamily includes
1. Facilitated transporters
2. Ion-coupled secondary active transporters
• It Contain hydrophobic transmembrane alpha helices
• Many serve as drug targets or in drug absorption and disposition
• Most members of the SLC group are located in the cell membrane
• Widely recognized SLC transporters include the serotonin & dopamine transporters
ManipalCollegeofPharmaceuticalSciences(MCOPS)
18. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
18
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS AS TARGETS FOR DRUGS
TYPES OF TRANSPORTERS….
STRUCTURE OF SLC TRANSPORTERS
19. • Membrane transporters play a critical role in the development of resistance
1. Anticancer drugs
2. Antimicrobial agents
3. Anticonvulsants
• P-glycoprotein is overexpressed in tumor cells after exposure to cytotoxic Anticancer
agents
• The over-expression of MRP4 is associated with resistance to Antiviral nucleoside
analogs
• Tumors arising from tissues where MDR1 is highly expressed show intrinsic resistance
to different Chemotherapeutic agents
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
19
ManipalCollegeofPharmaceuticalSciences(MCOPS)
MEMBRANE TRANSPORT & DRUG
RESISTANCE
TRANSPORTERS AS TARGETS FOR DRUGS
20. Reversal agents
o 1st Generation- eg cyclosporine, verapamil
o 2nd Generation- eg valspodar, biricodar
o 3rd Generation- eg tariquidar, zosuquidar, laniquidar
Thiomers
o Eg α-Chitosan–thiobutylamidine (chito– TBA)
Nanocarrier drug delivery system
o Liposomes
20
ManipalCollegeofPharmaceuticalSciences(MCOPS)
MEMBRANE TRANSPORT & DRUG RESISTANCE
TRANSPORTERS AS TARGETS FOR DRUGS
NOVEL APPROACHES TO OVERCOME RESISTANCE
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
21. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
21
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
HEPATIC TRANSPORTERS
1. Organic anion transporters- OATPs
2. Organic cation transporters-
o OCTs & NTCP for cations & bile salts
o Uptake either by facilitated or secondary active mechanisms
3. ABC transporters such as MRP2, MDR1, BCRP, BSEP & MDR2-
o Mediate efflux (excretion) of drugs & their metabolites, bile salts &
phospholipids
o Against concentration gradient from liver to bile
o This primary active transport is driven by ATP
22. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
22
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
HEPATIC TRANSPORTERS...
23. 1. HMG-COA Reductase inhibitor-
Statins are cholesterol-lowering agents that reversibly inhibit HMG-CoA
reductase enzyme
2. Temocapril-
It is an ACE inhibitor temocaprilat & is excreted both in bile & urine whereas
other ACEI’s are excreted mainly via the kidney
3. Irinotecan (CPT-11)-
It is a potent anticancer drug in late-onset it causes gastrointestinal toxic effects
but after IV administration then excreted into the bile by MRP2
4. Troglitazone
23
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
DRUGS THAT ACT ON HEPATIC TRANSPORTERS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
24. Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
24
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
RENAL TRANSPORTERS
25. • Transporters assigned to the apical membrane are in the SLC 22 family
• OCT family involves the uptake of a variety of organic cations
• Drugs that act on OCT are dopamine, choline, N-methylnicotinamide & cimetidine,
ranitidine, metformin, procainamide, and N-acetylprocainamide
• OAT family involves the uptake of a variety of organic anions
• Primary function of organic anion transporters is the removal of xenobiotics include
weak acidic drugs e.g. pravastatin, captopril, pencillins & toxins
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of Pharmaceutics
25
ManipalCollegeofPharmaceuticalSciences(MCOPS)
TRANSPORTERS INVOLVED IN
PHARMACOKINECTICS
TRANSPORTERS AS TARGETS FOR DRUGS
RENAL TRANSPORTERS
26. Transporters are needed
To regulate bioavailability
To act as drug targets
To eliminate toxins
To overcome resistance
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of
Pharmaceutics 26
ManipalCollegeofPharmaceuticalSciences(MCOPS)
CONCLUSION
TRANSPORTERS AS TARGETS FOR DRUGS
27. 1. Laurence L. B, Bruce A. C, Bjorn C.K, Goodman & Gillman's The Pharmacological
Basis of Therapeutics, McGraw Hill Education; 12 edition (2011), pp.no: 41-70
2. Cooper.G.M, Hausman .E.R (2009), Transport of small molecules, The cell a
molecular approach (fifth edition) , Boston, Sinauer associates, pp.no: 540-571
3. Tortora.G.J, Derrickson. B (2009), Transport across the plasma membrane,
Principles of anatomy and physiology(twelth edition), John wiley and sons, pp.no:
56-72
4. Rang H & Dale M. (2012). Rang and Dale's pharmacology. Elsevier/ Churchill
Livingstone, Edinburgh, pp.294-304
27
ManipalCollegeofPharmaceuticalSciences(MCOPS)
REFERENCES
TRANSPORTERS AS TARGETS FOR DRUGS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of
Pharmaceutics
29. 29
ManipalCollegeofPharmaceuticalSciences(MCOPS)
My sincere thanks to all my respected professors of MCOPS and my
special thanks to Dr. K B Koteshwara sir; without his guidance I would
not be able to put up my presentation to you.
-Shikha Singh (Ist year Mpharm-Industrial Pharmacy)
TRANSPORTERS AS TARGETS FOR DRUGS
Presented by SHIKHA Y SINGH; under the guidance of Dr. K B Koteshwara.; MCOPS-Department of
Pharmaceutics
Editor's Notes
Secondary- no atp coupling potential difference is used to pump out of the cell
Facilitated conc gradient
Regulating the distribution and bioavailability of drugs
Genes gives function to d transporters
Atp coupled n & c terminal changes depending upon the transport
Both ABC importers and exporters have a common mechanism in transporting substrates because of the similarities in their structures.
For importers, In this outward-facing conformation will have higher binding affinity for substrate. since translocation is directed from the periplasm to the cytoplasm.
For exporters, In this inward-facing conformation will have higher binding affinity for substrate. since translocation is directed from the cytoplasm to the periplasm
This model presents 2 principal conformation of the NBDs
Formation of a A closed dimer on binding of the 2 ATP molecules
Dissociation to an open dimer facilitated by the ATP hydrolysis
Switching between the 2 conformations induces a conformational change in the TMD resulting in substrate translocation
(SERT, encoded by SLC6A4; DAT, encoded by SLC6A3). Located in cell membrane
Secondary- no atp coupling potential difference is used to pump out of the cell
Facilitated conc gradient No energy required widely used in d brain
multidrug-resistance protein
Liposomes me phospholipid get sacrifice
Thiol grp pgp inhibitor
Competitive inhibitors